| Trial Identifier: | D8220R00038 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT05140369 |
| Start Date: | October 2021 |
| Primary Completion Date: | December 2026 |
| Study Completion Date: | December 2026 |
| Condition: | CLL (Chronic Lymphocytic Leukemia) |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| Russia | Belgorod, Russia |
| Russia | Bryansk, Russia |
| Russia | Buriatia, Russia |
| Russia | Chelyabinsk, Russia |
| Russia | Chita, Russia |
| Russia | Ekaterinburg, Russia |
| Russia | Irkutsk, Russia |
| Russia | Kaliningrad, Russia |
| Russia | Kaluga, Russia |
| Russia | Kazan, Russia |
| Russia | Kirov, Russia |
| Russia | Krasnoyarsk, Russia |
| Russia | Kurgan, Russia |
| Russia | Mahachkala, Russia |
| Russia | Moscow, Russia |
| Russia | Nizhniy Novgorod, Russia |
| Russia | Novosibirsk, Russia |
| Russia | Omsk, Russia |
| Russia | Orenburg, Russia |
| Russia | Petrozavodsk, Russia |
| Russia | Rostov on Don, Russia |
| Russia | Saint Petersburg, Russia |
| Russia | Samara, Russia |
| Russia | Saratov, Russia |
| Russia | Syktyvkar, Russia |
| Russia | Tver, Russia |
| Russia | Ufa, Russia |
| Russia | Ulan-Ude, Russia |
| Russia | Vladimir, Russia |
| Russia | Volgograd, Russia |
| Russia | Vologda, Russia |
| Russia | Yaroslavl, Russia |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company